Health

608 bookmarks
Newest
Newer Agents for the Management of Overactive Bladder
Newer Agents for the Management of Overactive Bladder
The anticholinergics tolterodine and oxybutynin are well established in the management of overactive bladder. However, their activity at muscarinic receptors distant from the target site (i.e., bladder) produces anticholinergic side effects leading to poor tolerability. In 2004, trospium, solifenacin, and darifenacin were approved by the U.S. Food and Drug Administration for the treatment of overactive bladder. Trospium is water soluble and therefore is less likely to enter the central nervous system, and solifenacin and darifenacin are more selective for the bladder than older agents. Although these attributes could improve tolerability, clinical trials comparing relevant agents to validate this are lacking. Trials have shown that these newer agents decrease the frequency of incontinence episodes, the number of voids per day, and the number and severity of urgency episodes compared with placebo. These agents also have been shown to improve quality of life in women with overactive bladder and urinary incontinence. Head-to-head studies of the newer agents and immediate-release oxybutynin and tolterodine have suggested similar effectiveness across the class, although the newer agents are better tolerated. Trospium and darifenacin have not been compared with extended-release formulations of tolterodine or oxybutynin, which are better tolerated than the immediate-release versions. In one study, solifenacin produced a somewhat greater decrease in the number of incontinence episodes than extended-release tolterodine, with no difference in tolerability. In general, the newer agents appear to be at least as effective as their predecessors, although it is unclear whether they are better tolerated. Important pharmacokinetic differences among the agents (e.g., route of elimination) allow for selection of an appropriate agent based on individual factors such as cost and tolerability.
anticholinergic
solifenacin produced a somewhat greater decrease in the number of incontinence episodes than extended-release tolterodine, with no difference in tolerability
·aafp.org·
Newer Agents for the Management of Overactive Bladder
Transdiagnostic cognitive behavioral therapy for nightmares and parasomnias | Journal of Clinical Sleep Medicine
Transdiagnostic cognitive behavioral therapy for nightmares and parasomnias | Journal of Clinical Sleep Medicine
Study Objectives: This pilot study determined whether transdiagnostic cognitive behavioral therapy for parasomnias (CBTp) reduces parasomnia and activity levels during sleep in a sample of adult sleep clinic outpatients. A secondary objective was to assess ...
·jcsm.aasm.org·
Transdiagnostic cognitive behavioral therapy for nightmares and parasomnias | Journal of Clinical Sleep Medicine
Dimethyl Sulfoxide (DMSO) and Methylsulfonylmethane (MSM) for Osteoarthritis
Dimethyl Sulfoxide (DMSO) and Methylsulfonylmethane (MSM) for Osteoarthritis
Dimethyl sulfoxide (DMSO) and methylsulfonylmethane (MSM) are two chemically related substances that have been studied for osteoarthritis. DMSO is used topically (applied to the skin). MSM is sold as a dietary supplement, either alone or in combination with other ingredients such as glucosamine.
·nccih.nih.gov·
Dimethyl Sulfoxide (DMSO) and Methylsulfonylmethane (MSM) for Osteoarthritis
Neurogenic Bladder
Neurogenic Bladder
The muscles and nerves of the urinary system work together to hold and release urine at the right time. Nerves carry messages between the bladder and the spinal cord and brain. The messages tell the muscles of the bladder to either tighten or release. In neurogenic bladder, these nerves don’t work the way they should.
·hopkinsmedicine.org·
Neurogenic Bladder
Dose Equivalents for Antipsychotic Drugs: The DDD Method
Dose Equivalents for Antipsychotic Drugs: The DDD Method
Dose equivalents of antipsychotics are an important but difficult to define concept, because all methods have weaknesses and strongholds.We calculated dose equivalents based on defined daily doses (DDDs) presented by the World Health Organisation’s ...
Aripiprazole
·ncbi.nlm.nih.gov·
Dose Equivalents for Antipsychotic Drugs: The DDD Method
USP Verified Dietary Supplements
USP Verified Dietary Supplements
Over 100 different dietary supplement formulas have received the USP Verified Mark, representing several different brands and retailers. Here are three different ways you can find a quality supplement.
·quality-supplements.org·
USP Verified Dietary Supplements
Folate Deficiency: Symptoms, Causes & Prevention
Folate Deficiency: Symptoms, Causes & Prevention
Folate deficiency occurs when your blood lacks the amount of folate it needs to function properly. Folate deficiency can cause a wide range of complications.
·my.clevelandclinic.org·
Folate Deficiency: Symptoms, Causes & Prevention
Myoclonic Disorders
Myoclonic Disorders
Few movement disorders seem to make a straightforward approach to diagnosis and treatment more difficult and frustrating than myoclonus, due to its plethora of causes and its variable classifications. Nevertheless, in recent years, exciting advances have ...
·ncbi.nlm.nih.gov·
Myoclonic Disorders
Rapid efficacy of aripiprazole in the treatment of catatonic depression/catatonia with consideration of the drug's unique receptor profile: a case report - PubMed
Rapid efficacy of aripiprazole in the treatment of catatonic depression/catatonia with consideration of the drug's unique receptor profile: a case report - PubMed
Catatonia is a widespread problem in psychiatric hospitals as approximately 10% of patients present with catatonic symptoms upon admission. Catatonia carries the risk of severe, even fatal complications. The first line treatment is usually electroconvulsive therapy (ECT) or benzodiazepines, but ECT …
·pubmed.ncbi.nlm.nih.gov·
Rapid efficacy of aripiprazole in the treatment of catatonic depression/catatonia with consideration of the drug's unique receptor profile: a case report - PubMed
How Tryptophan Can Help Sleep, Mood and Even ADHD
How Tryptophan Can Help Sleep, Mood and Even ADHD
Tryptophan is an amino acid that's a building blocks of protein and helps humans thrive. Eating tryptophan foods or taking supplements can help bring on natural calming effects, induces sleep, fights anxiety and even help with ADHD.
·draxe.com·
How Tryptophan Can Help Sleep, Mood and Even ADHD
Deficiency in taurine amino acid may speed up ageing process, say scientists
Deficiency in taurine amino acid may speed up ageing process, say scientists
supports immune health and nervous system function. daily intake of 500 and 1000 milligrams of taurine supplement per kg of body weight was also associated with improvements in strength, coordination, and cognitive functions.
immune health and nervous system function
daily intake of 500 and 1000 milligrams of taurine supplement per kg of body weight was also associated with improvements in strength, coordination, and cognitive functions
animals lived longer, we also found that they're living healthier lives.
improvements in their immune systems, bone density and overall metabolic health.
people with higher taurine levels were much healthier
fewer cases of type 2 diabetes, lower obesity levels, and lower levels of inflammation.
all had increased taurine levels after exercise, which suggests that some of the health benefits of exercise may come from an increase in taurine,
·news.sky.com·
Deficiency in taurine amino acid may speed up ageing process, say scientists
Homocystinuria: Challenges in diagnosis and management
Homocystinuria: Challenges in diagnosis and management
Two patients with homocystinuria are discussed. Both patients presented with behavioural abnormalities and deficits in attention – symptoms that are frequently encountered in paediatric office practice. In both cases, the diagnosis of homocystinuria ...
·ncbi.nlm.nih.gov·
Homocystinuria: Challenges in diagnosis and management